@article{f8d4c54f2a8f4c32a367fcf3288c21d5,
title = "Progressing polypills beyond concepts to outcomes",
author = "Patel, {Anushka A.} and Huffman, {Mark D.}",
note = "Funding Information: AAP declares that her employer's wholly owned social enterprise, George Health Enterprises, has received investment funds to develop fixed-dose combination products containing aspirin, statin, and blood pressure-lowering drugs. AAP reports grants from the Australian National Health and Medical Research Council, outside the area of work commented on here. MDH reports grants from the World Heart Federation via Boehringer Ingelheim and Novartis, grants from One Brave Idea via the American Heart Association, Verily, and AstraZeneca, grants from the National Heart, Lung, and Blood Institute, and personal fees from the American Medical Association, all outside the area of work commented on here.",
year = "2019",
month = aug,
day = "24",
doi = "10.1016/S0140-6736(19)31953-1",
language = "English (US)",
volume = "394",
pages = "617--619",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10199",
}